Zurueck zur Suche

Reporte zur Charge UJ893AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
1Bleibende Schaeden
PA 3 NY 1 TX 1 AL 1 ID 1 AZ 1 LA 1 CO 1 SC 1 OR 1

VAERS 2528922

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

schwer
Staat
NY
Alter
54,0
Geschlecht
F
Eingang
12.12.2022
Impfdatum
13.11.2022
Beginn
24.11.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Back pain Chest X-ray Gait disturbance Guillain-Barre syndrome Hypoaesthesia Hypoaesthesia oral Hyporeflexia Immunoglobulin therapy Laboratory test Lumbar puncture abnormal Mobility decreased Musculoskeletal disorder Pain Pain in extremity Paraesthesia Paraesthesia oral Sleep disorder Spinal X-ray

Symptomtext

On 11/24 the patient first noticed symptoms at 3 am when getting up to walk to the bathroom. She reported tingling and numbness in her feet and hands at that time. That same day around 11am the patient noticed difficulty lifting her legs to walk up the stairs. By the evening her left leg appeared to be dragging. She then started to get intolerable pain in her legs and back that evening when going to bed. By saturday the patient ended up in the emergency room of hospital. There they did thoracic x-ray and general testing. In conclusive results at the time and she was prescribed hydrocodone-acetaminophen, prednisone, ibuprofen and cyclobenzaprine. She was told to follow up with primary and orthopedic. Unable to sleep saturday night due to pain and called on call service on sunday. Md called back and thought it may have been guillain-barre sydrome and suggested the patient go to hospital to seek further treatment. Hospital refused spinal tap due to the fact that she had limited mobility and reflexes in the legs. Monday morning the patient went back to hospital due to persistent pain. Attempted a spinal tap but unable to get. The patient was walking with a cane at this point due to loss of function in the legs. Patient was admitted to Hospital. Tuesday patient went to x-ray and then underwent a spinal tap where results came back positive for guillain-barre syndrome. Was using a walker on Tuesday and then by Thursday had complete loss in function of legs with some numbness and tingling of the tongue/face. Wednesday started on IVIG treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
21,0
Labordaten
See above
Aktuelle Erkrankungen
No history of illness
Vorgeschichte
No health conditions
Andere Medikamente
Vitamin C, Vitamin B complex, Zinc
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2518134

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

moderat
Staat
TX
Alter
50,0
Geschlecht
F
Eingang
28.11.2022
Impfdatum
14.11.2022
Beginn
14.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased

Symptomtext

Patient said she has had a hard time moving her right arm since she received the flu vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475423

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj893AB

moderat
Staat
AL
Alter
50,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dysphonia Dyspnoea Eye swelling Nasal pruritus Rhinorrhoea Throat tightness

Symptomtext

Approximately 15 minutes after receiving flu vaccine, patient developed moderate shortness of breath, hoarseness, throat feeling tight, eyes swelling and itchy, runny nose. Patient took Cetirizine 10mg X 1 and repeated 2 hours later. Prednisone pack and famotidine prescriptions were started around 4-6 hours later. prescribed by her physician. Full resolution of symptoms achieved 10/8/22 in late afternoon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
Multiple vitamins once daily
Allergien
Eggs, peanuts, eucalyptus
Vorherige Impfungen
2009 Flu shot. unknown brand. tightness in throat, itchy swollen eyes.

VAERS 2523022

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

mild
Staat
PA
Alter
36,0
Geschlecht
M
Eingang
05.12.2022
Impfdatum
14.11.2022
Beginn
14.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain Tenderness

Symptomtext

Employee is still have tenderness with movement

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2521077

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

mild
Staat
ID
Alter
53,0
Geschlecht
M
Eingang
01.12.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Blood creatine increased Blood test Muscular weakness Myalgia Myositis Pain Pain in extremity

Symptomtext

Experienced muscle aches at thighs hours after vaccination. The started radiating to hips about 4 days later. Pain began to increase for two weeks. Went to hospital, diagnosed with myositis (creatine was high). Following up with clinician , started physical therapy on 11/15/2022. Still experiencing mild pain and muscle weakness after standing/walking for a short time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Blood work completed at hospital
Aktuelle Erkrankungen
None
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2480441

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

mild
Staat
PA
Alter
53,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
04.10.2022
Beginn
04.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Heart rate increased

Symptomtext

experienced fatigue and elevated HR 150 x72 hours

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
States received vaccine in the afternoon on 10/04/2022 by 7pm that evening began with extreme fatigue and elevated heart rate 150
Allergien
penicillin, IVP dye, shellfish
Vorherige Impfungen
-

VAERS 2471809

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

mild
Staat
PA
Alter
44,0
Geschlecht
M
Eingang
07.10.2022
Impfdatum
06.10.2022
Beginn
06.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Erythema Rash Urticaria Wheezing

Symptomtext

Initially hands became reddened. Rash on arms began around 1:30 p.m. Hives on arms Wheezing began around 2:00 p.m. Whole body hives. Went to the ED for treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Unknown to me as I am the Nurse. The patient is an RN and can explain in more detail.
Aktuelle Erkrankungen
-
Vorgeschichte
Heart issues
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2527818

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

gering
Staat
AZ
Alter
17,0
Geschlecht
F
Eingang
09.12.2022
Impfdatum
28.09.2022
Beginn
28.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

There was no adverse event. The patient had no reaction to the medication.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2506583

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ893AB

gering
Staat
LA
Alter
66,0
Geschlecht
F
Eingang
12.11.2022
Impfdatum
31.10.2022
Beginn
31.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Medication error Wrong product administered

Symptomtext

administration of FLUBLOK instead of FLUZONE HIGH-DOSE QUADRIVALENT to a patient over 65 years of age with no reported AE; FLUBLOK accidentally given instead of FLUZONE HIGH-DOSE QUADRIVALENT to a patient over 65 years of age with no reported AE; Initial information on 07-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer/Non-HCP. This case involves a 66 years old female patient who was administered flublok instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae and flublok accidentally given instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae while receiving vaccine influenza quadrival a-b vaccine [fluzone qiv]. The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided. On 31-Oct-2022, the patient received a dose of suspect influenza quadrival a-b vaccine (dose- o.5 ml daily (QD), lot UJ893AB via intramuscular route in the left deltoid and expiration date- 09-Jun-2023) (strength and formulation : not reported) as influenza. On 31-OCT-2022 the patient was administered flublok instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae (wrong product administered) and flublok accidentally given instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae (accidental exposure to product) (latency- same day for both events) following the administration of influenza quadrival a-b vaccine. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (administration of FLUBLOK instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae, flublok accidentally given instead of FLUZONE HIGH-DOSE QUADRIVALENT to a patient over 65 years of age with no reported AE). At time of reporting, the outcome was Unknown for the event administration of flublok instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae and was Unknown for the event flublok accidentally given instead of fluzone high-dose quadrivalent to a patient over 65 years of age with no reported ae. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2499557

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj893ab

gering
Staat
CO
Alter
38,0
Geschlecht
M
Eingang
04.11.2022
Impfdatum
04.11.2022
Beginn
01.11.2022
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

The patient came in for a Pfizer Covid Booster, but the pharmacy gave Flublok instead. However, the patient hasn't gotten Flu shot for the year 2022. So the patient got both shots today 11-4-22 FluBlok and Pfizer Bivalent Booster. No reaction has been seen yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
None
Allergien
NA
Vorherige Impfungen
-

VAERS 2485010

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ893AB

gering
Staat
SC
Alter
7,0
Geschlecht
M
Eingang
21.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Product use issue

Symptomtext

7-year-old child received the flubok (with no reported adverse event); Initial information regarding an unsolicited valid non-serious case received via health professional on 14-Oct-2022. GMI number: 01322654 This case involves a 7-year-old male child received Influenza Quadrivalent Recombinant Vaccine [Flublok] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 14-Oct-2022, the 7-year-old male child received suspect Flublok vaccine at dose 0.5ml once (lot: UJ893AB, expiry date: 09-Jun-2023) via intramuscular route in the right deltoid for Immunization with no reported adverse event) (product use issue) at same day latency. It was reported that "Physician office staff is calling to report that a 7-year-old child received the FLUBLOK. Caller is wanting to know what to do and what side effects the child may have. This situation is reported as a medication error due to giving the medication to not approved age." Action taken: Not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2473417

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ893AB

gering
Staat
OR
Alter
3,0
Geschlecht
M
Eingang
10.10.2022
Impfdatum
07.10.2022
Beginn
07.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Flublox given to 3 year old by mistake

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
none indicated on screening form
Andere Medikamente
Unknown
Allergien
None indicated on screening form
Vorherige Impfungen
-